Microscopic view of primary immunodeficiency disease

Privigen® CIDP

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Product Information	Educational Materials	Conferences and Events	Key Publications

Key Publications

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label phase III study (PRIMA)

Léger, J-M et al
J Periph Nerv Syst 2013
Request | Ask a Question | View Article

Restabilization treatment after IVIg withdrawal in chronic inflammatory demyelinating polyneuropathy. Results from the pre-randomization phase of the PATH study

Mielke, O et al
J Periph Nerv Syst 2019
Request | Ask a Question | View Article